Sector Gamma As as of June 30, 2018
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 32 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Abbott Laboratories (ABT) | 10.8 | $65M | 1.1M | 60.99 | |
Merck & Co (MRK) | 9.2 | $56M | 914k | 60.70 | |
Baxter International (BAX) | 8.8 | $53M | 721k | 73.84 | |
Bristol Myers Squibb (BMY) | 8.3 | $50M | 902k | 55.34 | |
Boston Scientific Corporation (BSX) | 7.9 | $48M | 1.5M | 32.70 | |
Shire | 4.8 | $29M | 172k | 168.80 | |
AstraZeneca (AZN) | 4.7 | $28M | 801k | 35.11 | |
PerkinElmer (RVTY) | 4.4 | $27M | 363k | 73.23 | |
Bio-Rad Laboratories (BIO) | 4.2 | $25M | 86k | 288.54 | |
Integra LifeSciences Holdings (IART) | 3.5 | $21M | 327k | 64.41 | |
Anthem (ELV) | 3.5 | $21M | 88k | 238.03 | |
Gilead Sciences (GILD) | 3.4 | $21M | 292k | 70.84 | |
NuVasive | 3.3 | $20M | 376k | 52.12 | |
Eli Lilly & Co. (LLY) | 2.6 | $16M | 182k | 85.33 | |
Perrigo Company (PRGO) | 2.4 | $15M | 199k | 72.91 | |
Ionis Pharmaceuticals (IONS) | 2.1 | $13M | 303k | 41.67 | |
Universal Health Services (UHS) | 1.8 | $11M | 99k | 111.44 | |
Lexicon Pharmaceuticals (LXRX) | 1.7 | $10M | 863k | 12.00 | |
Regeneron Pharmaceuticals (REGN) | 1.6 | $9.8M | 29k | 344.98 | |
Laboratory Corp. of America Holdings (LH) | 1.5 | $9.3M | 52k | 179.52 | |
Ironwood Pharmaceuticals (IRWD) | 1.4 | $8.1M | 424k | 19.12 | |
Clovis Oncology | 1.3 | $7.9M | 174k | 45.47 | |
Portola Pharmaceuticals | 1.3 | $7.6M | 201k | 37.77 | |
Patterson Companies (PDCO) | 1.2 | $7.1M | 312k | 22.67 | |
Cardinal Health (CAH) | 1.0 | $6.2M | 126k | 48.83 | |
Ultragenyx Pharmaceutical (RARE) | 0.9 | $5.2M | 68k | 76.87 | |
Alnylam Pharmaceuticals (ALNY) | 0.5 | $3.2M | 33k | 98.49 | |
Tenet Healthcare Corporation (THC) | 0.5 | $3.0M | 91k | 33.57 | |
Bluebird Bio (BLUE) | 0.4 | $2.7M | 17k | 156.94 | |
Spark Therapeutics | 0.4 | $2.6M | 32k | 82.75 | |
Sangamo Biosciences (SGMO) | 0.3 | $2.1M | 146k | 14.20 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $718k | 10k | 71.80 |